- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Melissa Johnson Underscores the Need for Lung Cancer Screening Guidance for Never-Smokers
Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, discusses the need for increased lung cancer screening among patients who have no tobacco use history.
We currently do not have a system in place for screening never-smokers for lung cancer, explained Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon.
Transcript
Is enough being done to identify patients who should be screened for lung cancer, including never-smokers?
We know that screening patients for lung cancers decreases the number of patients being diagnosed with lung cancer each year. The problem is that the [National Lung Screening Trial] data is not always generalizable to all patients. You mentioned the never-smokers. It's a really good question. We don't have a mechanism for screening never-smokers. Just in 2021, we have decreased the number of pack-years required from 30 pack-years to 20 pack-years and decreased the age from 55 to 50 for patients to make them eligible for screening. And so those are steps in the right direction. But we'll never get to never-smokers if we're just looking for patients that have a tobacco screening history. In parts of the world such as Asia, 50% of lung cancer patients will be never-smokers. And so that shows us that our current ways of selecting patients (ie, their tobacco exposure history) are neither sufficient nor far-reaching enough to really be identifying those patients most at risk because they're not thinking about it.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
Expanding Access to NSCLC Innovations: Challenges and Opportunities
October 18th 2024The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and improving treatment access, in particular for immunotherapy and targeted treatments.
Read More
